Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics
Background: Cholesterol and blood pressure (BP) can be effectively and safely lowered with statin drugs and BP-lowering drugs, reducing major cardiovascular (CV) events by 20%-30% within 5 years in high-risk individuals. However, there are limited data in lower-risk populations. The Heart Outcomes P...
الحاوية / القاعدة: | Canadian Journal of Cardiology |
---|---|
المؤلف الرئيسي: | |
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Elsevier Inc.
2016
|
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959279879&doi=10.1016%2fj.cjca.2015.07.001&partnerID=40&md5=f6832d88b7627fbe40a5bb45ad1c94c6 |